4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Solara Active Pharma Sciences Limited (SOLARA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Chennai, India with about 1,669 employees. Its market capitalization is roughly ₹36 billion. In the fiscal year ended 2026-03-31, SOLARA reported ₹13.3B in revenue and (₹74M) in net income.
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America, South America, and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹13.3B | ₹12.4B | ₹12.4B | ₹13.8B | — |
| Gross Profit | ₹6.2B | ₹6.0B | ₹4.0B | ₹5.7B | — |
| Operating Income (EBIT) | ₹879M | ₹1.1B | (₹2.0B) | ₹332M | — |
| Net Income | (₹74M) | ₹5M | (₹5.7B) | (₹222M) | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | ₹3.8B | ₹3.9B | ₹3.5B | ₹3.1B | ₹3.2B | — | — |
| Gross Profit | ₹1.9B | ₹1.9B | ₹1.6B | ₹1.6B | ₹1.7B | — | — |
| Operating Income (EBIT) | ₹353M | ₹316M | ₹118M | ₹102M | ₹334M | — | — |
| Net Income | ₹163M | ₹96M | (₹174M) | (₹101M) | ₹105M | — | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | — | (₹108M) |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹23.3B | ₹22.3B | ₹23.5B | ₹29.0B | — |
| Total Liabilities | ₹10.8B | ₹11.3B | ₹14.1B | ₹14.0B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SOLARA viewer.
About TickerBase · Data methodology & sources · Privacy · Terms